Last 12 months
Inside the activity.
3 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 3 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 04, 2018 Filed Jan 5, 2018 22:27 UTC |
Cohen YuvalDirector · Chief Executive Officer
|
GrantStock Option(right to buy) · Derivative | 437,500 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0001209191-18-002512 · doc4.xml · derivative · entry 1 Cohen Yuval · CIK 0001626003 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,500 Underlying: Common Stock · 437,500 shares Expires 2028-01-04 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on January 4, 2019, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 4, 2019. Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 15:04 UTC |
Panayiotopoulos ParisDirector
|
PurchaseCommon Stock | 14,285 | $7.03 | $100,392.12 |
DisclosureSEC source: 0001209191-17-061358 · doc4.xml · nonDerivative · entry 1 Panayiotopoulos Paris · CIK 0001662996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,285 Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 08:54 UTC |
Hochman David PDirector
|
PurchaseCommon Stock | 5,000 | $6.55 | $32,750.00 |
DisclosureSEC source: 0001209191-17-061052 · doc4.xml · nonDerivative · entry 5 Hochman David P · CIK 0001292834 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By NSH 2008 Family Trust Disclosed balance after: 220,000 Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 10:56 UTC Amendment |
Hochman David PDirector
|
PurchaseCommon Stock | 5,000 | $6.90 | $34,500.00 |
DisclosureSEC source: 0001209191-17-060534 · doc4a.xml · nonDerivative · entry 5 Hochman David P · CIK 0001292834 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By NSH 2008 Family Trust Disclosed balance after: 215,000 F1 · kind: The transaction code in Column 3 reported on the Form 4 filed on November 14, 2017 was incorrectly stated as "A" and is being corrected herein via this filing. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 09:15 UTC |
Hochman David PDirector
|
GrantCommon Stock | 5,000 | $6.90 | $34,500.00 |
DisclosureSEC source: 0001209191-17-060502 · doc4.xml · nonDerivative · entry 5 Hochman David P · CIK 0001292834 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By NSH 2008 Family Trust Disclosed balance after: 215,000 Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 11:16 UTC |
White BarbaraChief Medical Officer
|
PurchaseCommon Stock | 2,836 | $7.00 | $19,852.00 |
DisclosureSEC source: 0001209191-17-060196 · doc4.xml · nonDerivative · entry 1 White Barbara · CIK 0001625844 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,050 Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 18:09 UTC |
Moran Sean F.Chief Financial Officer
|
PurchaseCommon Stock | 1,500 | $7.04 | $10,560.00 |
DisclosureSEC source: 0001209191-17-060218 · doc4.xml · nonDerivative · entry 1 Moran Sean F. · CIK 0001451495 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,910 Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 10:33 UTC |
Hochman David PDirector
|
PurchaseCommon Stock | 10,000 | $7.08 | $70,800.00 |
DisclosureSEC source: 0001209191-17-060177 · doc4.xml · nonDerivative · entry 1 Hochman David P · CIK 0001292834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,500 Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 13:59 UTC |
Cohen YuvalDirector · Chief Executive Officer
|
PurchaseCommon Stock | 1,000 | $7.17 | $7,168.50 |
DisclosureSEC source: 0001209191-17-060145 · doc4.xml · nonDerivative · entry 1 Cohen Yuval · CIK 0001626003 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,775 Read SEC document |
| October 16, 2017 Filed Oct 18, 2017 11:50 UTC |
Panayiotopoulos ParisDirector
|
GrantStock Option(right to buy) · Derivative | 61,000 | $0.00 Strike: $6.90 | $0.00 |
DisclosureSEC source: 0001209191-17-057230 · doc4.xml · derivative · entry 1 Panayiotopoulos Paris · CIK 0001662996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,000 Underlying: Common Stock · 61,000 shares Expires 2027-10-16 F1 · security: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. Read SEC document |
| August 11, 2017 Filed Aug 11, 2017 13:34 UTC |
White BarbaraChief Medical Officer
|
PurchaseCommon Stock | 2,479 | $6.05 | $14,997.95 |
DisclosureSEC source: 0001209191-17-048536 · doc4.xml · nonDerivative · entry 1 White Barbara · CIK 0001625844 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,214 Read SEC document |
| August 11, 2017 Filed Aug 11, 2017 14:01 UTC |
Moran Sean F.Chief Financial Officer
|
PurchaseCommon Stock | 2,500 | $5.91 | $14,775.00 |
DisclosureSEC source: 0001209191-17-048508 · doc4.xml · nonDerivative · entry 1 Moran Sean F. · CIK 0001451495 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,410 Read SEC document |
| August 11, 2017 Filed Aug 11, 2017 17:17 UTC |
Cohen YuvalDirector · Chief Executive Officer
|
PurchaseCommon Stock | 1,695 | $6.00 | $10,170.00 |
DisclosureSEC source: 0001209191-17-048535 · doc4.xml · nonDerivative · entry 1 Cohen Yuval · CIK 0001626003 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,775 Read SEC document |
| May 25, 2017 Filed May 26, 2017 16:36 UTC |
Hochman David PDirector
|
GrantStock Option(right to buy) · Derivative | 30,500 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0001209191-17-035844 · doc4.xml · derivative · entry 1 Hochman David P · CIK 0001292834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 30,500 shares Expires 2027-05-25 F1 · deemedExecutionDate: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. Read SEC document |
| May 25, 2017 Filed May 26, 2017 16:40 UTC |
GUPTA RENUDirector
|
GrantStock Option(right to buy) · Derivative | 30,500 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0001209191-17-035861 · doc4.xml · derivative · entry 1 GUPTA RENU · CIK 0001269592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 30,500 shares Expires 2027-05-25 F1 · deemedExecutionDate: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. Read SEC document |
| May 25, 2017 Filed May 26, 2017 16:39 UTC |
CATLIN AVERY WDirector
|
GrantStock Option(right to buy) · Derivative | 30,500 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0001209191-17-035856 · doc4.xml · derivative · entry 1 CATLIN AVERY W · CIK 0001255348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 30,500 shares Expires 2027-05-25 F1 · security: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. Read SEC document |
| May 25, 2017 Filed May 26, 2017 16:37 UTC |
HOLMER ALAN FDirector
|
GrantStock Option(right to buy) · Derivative | 30,500 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0001209191-17-035850 · doc4.xml · derivative · entry 1 HOLMER ALAN F · CIK 0001329585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 30,500 shares Expires 2027-05-25 F1 · deemedExecutionDate: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. Read SEC document |
| May 11, 2017 Filed May 12, 2017 10:00 UTC |
White BarbaraChief Medical Officer
|
PurchaseCommon Stock | 2,435 | $6.12 | $14,904.64 |
DisclosureSEC source: 0001209191-17-031715 · doc4.xml · nonDerivative · entry 1 White Barbara · CIK 0001625844 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,735 Read SEC document |
| May 11, 2017 Filed May 12, 2017 16:56 UTC |
Moran Sean F.Chief Financial Officer
|
PurchaseCommon Stock | 3,300 | $6.14 | $20,262.00 |
DisclosureSEC source: 0001209191-17-031793 · doc4.xml · nonDerivative · entry 1 Moran Sean F. · CIK 0001451495 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,910 Read SEC document |
| May 11, 2017 Filed May 12, 2017 11:15 UTC |
Hochman David PDirector
|
PurchaseCommon Stock | 3,400 | $6.18 | $21,012.00 |
DisclosureSEC source: 0001209191-17-031751 · doc4.xml · nonDerivative · entry 1 Hochman David P · CIK 0001292834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,500 Read SEC document |
| May 11, 2017 Filed May 12, 2017 10:46 UTC |
CATLIN AVERY WDirector
|
PurchaseCommon Stock | 5,000 | $6.15 | $30,740.50 |
DisclosureSEC source: 0001209191-17-031737 · doc4.xml · nonDerivative · entry 1 CATLIN AVERY W · CIK 0001255348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,000 Read SEC document |
| May 11, 2017 Filed May 12, 2017 11:45 UTC |
HOLMER ALAN FDirector
|
PurchaseCommon Stock | 500 | $6.23 | $3,115.00 |
DisclosureSEC source: 0001209191-17-031765 · doc4.xml · nonDerivative · entry 1 HOLMER ALAN F · CIK 0001329585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Read SEC document |
| May 11, 2017 Filed May 12, 2017 13:03 UTC |
Cohen YuvalDirector · Chief Executive Officer
|
PurchaseCommon Stock | 3,250 | $6.01 | $19,539.00 |
DisclosureSEC source: 0001209191-17-031700 · doc4.xml · nonDerivative · entry 1 Cohen Yuval · CIK 0001626003 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,080 Read SEC document |
| March 17, 2017 Filed Mar 20, 2017 08:19 UTC |
White BarbaraChief Medical Officer
|
PurchaseCommon Stock | 4,233 | $9.49 | $40,171.17 |
DisclosureSEC source: 0001209191-17-021587 · doc4.xml · nonDerivative · entry 1 White Barbara · CIK 0001625844 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,300 Read SEC document |
| March 16, 2017 Filed Mar 17, 2017 11:58 UTC |
Cohen YuvalDirector · Chief Executive Officer
|
Exercise / conversionOptions to purchase common stock · Derivative | 20,000 | $1.00 Strike: $1.00 | $20,000.00 |
DisclosureSEC source: 0001209191-17-021246 · doc4.xml · derivative · entry 2 Cohen Yuval · CIK 0001626003 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,728 Underlying: Common stock · 20,000 shares Expires 2024-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2017 Filed Mar 17, 2017 11:58 UTC |
Cohen YuvalDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 20,000 | $1.00 | $20,000.00 |
DisclosureSEC source: 0001209191-17-021246 · doc4.xml · nonDerivative · entry 1 Cohen Yuval · CIK 0001626003 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2017 Filed Mar 13, 2017 13:54 UTC |
Moran Sean F.Chief Financial Officer
|
PurchaseCommon Stock | 2,000 | $9.60 | $19,200.00 |
DisclosureSEC source: 0001209191-17-020027 · doc4.xml · nonDerivative · entry 1 Moran Sean F. · CIK 0001451495 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,610 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:20 UTC |
White BarbaraChief Medical Officer
|
GrantStock Option(right to buy) · Derivative | 115,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001209191-17-017506 · doc4.xml · derivative · entry 1 White Barbara · CIK 0001625844 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2027-03-01 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 1, 2018, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 1, 2018. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:19 UTC |
Moran Sean F.Chief Financial Officer
|
GrantStock Option(right to buy) · Derivative | 115,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001209191-17-017485 · doc4.xml · derivative · entry 1 Moran Sean F. · CIK 0001451495 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2027-03-01 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 1, 2018, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 1, 2018. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:20 UTC |
Tepper MarkPresident and CSO
|
GrantStock Option(right to buy) · Derivative | 115,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001209191-17-017496 · doc4.xml · derivative · entry 1 Tepper Mark · CIK 0001291087 · President and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2027-03-01 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 1, 2018, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 1, 2018. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:17 UTC |
Cohen YuvalDirector · Chief Executive Officer
|
GrantStock Option(right to buy) · Derivative | 377,500 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001209191-17-017470 · doc4.xml · derivative · entry 1 Cohen Yuval · CIK 0001626003 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,500 Underlying: Common Stock · 377,500 shares Expires 2027-03-01 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 1, 2018, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 1, 2018. Read SEC document |
| December 02, 2016 Filed Dec 2, 2016 16:12 UTC |
Moran Sean F.Chief Financial Officer
|
PurchaseCommon Stock | 1,500 | $7.20 | $10,800.00 |
DisclosureSEC source: 0001209191-16-152835 · doc4.xml · nonDerivative · entry 1 Moran Sean F. · CIK 0001451495 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,610 Read SEC document |
| November 22, 2016 Filed Nov 22, 2016 14:40 UTC |
CATLIN AVERY WDirector
|
PurchaseCommon Stock | 2,000 | $7.55 | $15,100.00 |
DisclosureSEC source: 0001209191-16-151670 · doc4.xml · nonDerivative · entry 1 CATLIN AVERY W · CIK 0001255348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Read SEC document |
| November 22, 2016 Filed Nov 22, 2016 14:42 UTC |
HOLMER ALAN FDirector
|
PurchaseCommon Stock | 1,000 | $7.49 | $7,490.00 |
DisclosureSEC source: 0001209191-16-151671 · doc4.xml · nonDerivative · entry 1 HOLMER ALAN F · CIK 0001329585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 16:44 UTC |
Cohen YuvalDirector · Chief Executive Officer
|
PurchaseCommon Stock | 1,340 | $7.64 | $10,237.60 |
DisclosureSEC source: 0001209191-16-151867 · doc4.xml · nonDerivative · entry 1 Cohen Yuval · CIK 0001626003 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,830 Read SEC document |
| November 22, 2016 Filed Dec 1, 2016 11:29 UTC |
White BarbaraChief Medical Officer
|
PurchaseCommon Stock | 1,000 | $7.75 | $7,750.00 |
DisclosureSEC source: 0001209191-16-152591 · doc4.xml · nonDerivative · entry 1 White Barbara · CIK 0001625844 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,067 Read SEC document |
| November 22, 2016 Filed Jan 20, 2017 22:28 UTC Amendment |
Cohen YuvalDirector · Chief Executive Officer
|
PurchaseCommon Stock | 1,340 | $7.64 | $10,237.60 |
DisclosureSEC source: 0001209191-17-004954 · doc4a.xml · nonDerivative · entry 1 Cohen Yuval · CIK 0001626003 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,830 F1 · balance_after: This amendment is being filed solely for the purpose of correcting the number of securities reported in Box 5 to Table 1 to indicate the number of securities beneficially owned following the transaction. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 10:23 UTC |
Hochman David PDirector
|
PurchaseCommon Stock | 10,000 | $7.00 | $69,960.00 |
DisclosureSEC source: 0001209191-16-151350 · doc4.xml · nonDerivative · entry 1 Hochman David P · CIK 0001292834 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,100 Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 16:53 UTC |
White BarbaraChief Medical Officer
|
GrantStock Option(right to buy) · Derivative | 150,000 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001209191-16-145417 · doc4.xml · derivative · entry 1 White Barbara · CIK 0001625844 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2026-10-06 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on October 6, 2017, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on November 6, 2017. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 20:51 UTC |
Moran Sean F.Chief Financial Officer
|
GrantStock Option(right to buy) · Derivative | 150,000 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001209191-16-145414 · doc4.xml · derivative · entry 1 Moran Sean F. · CIK 0001451495 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2026-10-06 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on October 6, 2017, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on November 6, 2017. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 16:52 UTC |
Tepper MarkPresident and CSO
|
GrantStock Option(right to buy) · Derivative | 150,000 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001209191-16-145416 · doc4.xml · derivative · entry 1 Tepper Mark · CIK 0001291087 · President and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2026-10-06 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on October 6, 2017, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on November 6, 2017. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 20:50 UTC |
Cohen YuvalDirector · Chief Executive Officer
|
GrantStock Option(right to buy) · Derivative | 150,000 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001209191-16-145413 · doc4.xml · derivative · entry 1 Cohen Yuval · CIK 0001626003 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2026-10-06 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on October 6, 2017, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on November 6, 2017. Read SEC document |
| September 16, 2016 Filed Sep 20, 2016 16:55 UTC |
Hochman David PDirector
|
GrantStock Option(right to buy) · Derivative | 50,000 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0001209191-16-142167 · doc4.xml · derivative · entry 1 Hochman David P · CIK 0001292834 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Orchestra Medical Ventures, LLC of which David Hochman is the Managing Partner Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-09-16 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and 50% of the option award will vest on the three-month anniversary of the date of grant with the remainder of the option award vesting on the six-month anniversary of the date of grant. Read SEC document |
| September 08, 2016 Filed Sep 8, 2016 15:48 UTC |
Moran Sean F.Chief Financial Officer
|
PurchaseCommon Stock | 30,800 | $5.12 | $157,696.00 |
DisclosureSEC source: 0001209191-16-140481 · doc4.xml · nonDerivative · entry 1 Moran Sean F. · CIK 0001451495 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,110 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.